related to the Washington, D.C. program approved last year. ? For the third quarter of 2026, we estimate that health insurance exchange trends had an impact of slightly less than $25 million, which was consistent with the updated outlook provided in July. Exchange volumes declined 17% from the third quarter of 2025, accompanied by a similar increase in the number of self-pay volumes. ? At Palm Beach Gardens, our acute care de novo hospital remains in the early stages of ramping volumes across multiple service lines. Startup losses improved each month during the third quarter. While the ramp at this facility remains gradual, the progression supports our expectation for continued improvement as we enter Florida's seasonally busier winter period. ? In Washington, D.C., Cedar Hill Regional Medical Center operating losses were similar on a sequential basis, excluding supplemental payments. We continue to support the build-out of primary care and specialty physician practices in the community around the hospital and in our MOB. Because these practices remain at varying stages of developing their patient bases within the community, we now expect the hospital to reach operational breakeven in the first half of 2027, compared with our prior expectations of the fourth quarter of 2026. Taken together, Palm Beach Gardens and Cedar Hill are progressing, but their pace of maturation remains an important factor in the timing of margin improvement for the acute care segment. Turning to behavioral health, third quarter same facility net revenue increased 4.0%, supported by a 2.1% increase in same facility revenue per adjusted patient day and a 2.1% increase in same facility adjusted patient days. Volumes improved modestly compared with recent quarters, reflecting steady demand and greater emphasis on the continuum of outpatient levels of care. Included in our total behavioral health segment results are Talkspace and an acquisition we completed in our UK operations in July, offset by startup losses associated with two de novo projects and ongoing operating losses at Laurel Ridge while we work towards recertification. Given the mid quarter closing, Talkspace's contribution to third quarter earnings was immaterial. ? In our behavioral health segment, the net out-of-period headwind related to supplemental payments was approximately $8 million in the third quarter of 2026, due primarily to the new Washington, D.C. program benefit in the third quarter of 2025. ? For the third quarter of 2026, behavioral health segments, same facilities' salaries, wages, and benefits per adjusted patient day increased 3.6% over the prior year, improving further on a sequential basis due to continued moderation in headcount growth. Turning to cash flow and capital allocation, third quarter cash generated from operating activities was $637 million compared with $381 million during the same period last year. During the third quarter of 2026, we spent $214 million on capital expenditures, and we anticipate capital expenditures to be slightly below $1 billion for the full year of 2026. As several large acute care de novo and expansion projects are now completed, we expect capital expenditures to moderate towards $800 million beyond 2026. During the third quarter of 2026, we acquired $1.35 million of our own shares at a total cost of $242 million, bringing year-to-date share repurchases to a total of $690 million. As of September 30, 2026, we had $735 million repurchase authorization available pursuant to our stock buyback program, and we expect to remain active with share repurchase for the foreseeable future. From a balance sheet perspective, we ended the quarter with cash of $169 million, total debt of $5.7 billion, and leverage of $2.17 times. Total debt reflects the August refinancing of our September 2026 debt maturity and incremental borrowings associated with the talkspace acquisition. ? As of September 30, 2026, we had approximately $1.2 billion of additional borrowing capacity available pursuant to our revolving credit facility. We remain committed to maintaining leverage within our target range of two to three times. Finally, turning to our 2026 outlook, we are reiterating the financial and operating forecast ranges issued with our second quarter results in July. Based on year-to-date trends through the third quarter and the ongoing ramp of our acute care hospitals in Washington, D.C. and Palm Beach Gardens, Florida, we currently expect results to be towards the lower end of these ranges. ? The reiterated ranges reflect continued underlying operating improvement, balanced against the pace of de novo facility ramp ups and the other near-term variables discussed today. Operator, that concludes our prepared remarks, and we'd be pleased to answer questions at this time.
Passages & reports (27) 12:38 related to the Washington, D.C. program approved last year. Report 12:43 For Report 12:43 the third quarter of 2026, we estimate that health insurance exchange trends had an impact… Report 13:03 of self-pay volumes. Report 13:05 At Report 13:06 Palm Beach Gardens, our acute care de novo hospital remains in the early stages of ramping… Report 13:26 enter Florida's seasonally busier winter period. Report 13:29 In Report 13:29 Washington, D.C., Cedar Hill Regional Medical Center operating losses were similar on a se… Report 13:49 stages of developing their patient bases within the community, we now expect the hospital … Report 14:09 in the timing of margin improvement for the acute care segment. Turning to behavioral heal… Report 14:29 days. Volumes improved modestly compared with recent quarters, reflecting steady demand an… Report 14:49 losses associated with two de novo projects and ongoing operating losses at Laurel Ridge w… Report 15:04 In Report 15:04 our behavioral health segment, the net out-of-period headwind related to supplemental paym… Report 15:19 For Report 15:20 the third quarter of 2026, behavioral health segments, same facilities' salaries, wages, a… Report 15:40 third quarter cash generated from operating activities was $637 million compared with $381… Report 15:59 below $1 billion for the full year of 2026. As several large acute care de novo and expans… Report 16:19 we acquired $1.35 million of our own shares at a total cost of $242 million, bringing year… Report 16:39 buyback program, and we expect to remain active with share repurchase for the foreseeable … Report 16:59 August refinancing of our September 2026 debt maturity and incremental borrowings associat… Report 17:08 As Report 17:08 of September 30, 2026, we had approximately $1.2 billion of additional borrowing capacity … Report 17:28 operating forecast ranges issued with our second quarter results in July. Based on year-to… Report 17:45 The Report 17:45 reiterated ranges reflect continued underlying operating improvement, balanced against the… Report